The TRIL Centre has recently commenced a collaborative research project with Pfizer. The project will explore potential technology solutions that aim to better monitor and manage Alzheimer’s Disease patients in the home setting while providing additional support to their caregivers.
The project builds upon TRIL knowledge and expertise in Alzheimer’s Disease and its ability to develop technology solutions to meet a clinical need along with deploying those technologies into the homes of older people.
Pfizer, a leading innovator in bio-pharmaceuticals, is committed to exploring innovative projects and programmes which will enhance patients’ quality of life to enable improved care in the community thereby helping to ensure care is delivered in the most appropriate setting. David Gallagher, Managing Director of Pfizer’s commercial operations in Ireland believes “this type of project, and indeed collaboration, will provide great insight into how individuals interact with new technologies in healthcare and how multi party collaborations can add complimentary skills and expertise to accelerate their development”.
Pfizer and TRIL firmly believe there are significant opportunities for technology to be integrated into standard care models and pathways for Alzheimer’s Disease, with an outcome of improved quality of life for patients and their caregivers while reducing the overall costs of managing the disease. TRIL’s Principal Investigator on the project, Prof Brian Lawlor states “Technologies that can be deployed in the home and that assist with disease management have the potential to improve caregiver quality of life and delay institutionalisation in patients with Alzheimer’s disease”.
TRIL’s partnership with Pfizer builds on the strong linkage that TRIL has with industry, Seamus Small, TRIL Centre Manager comments “We are delighted to commence this innovative project with Pfizer. This is further evidence that TRIL’s knowhow and capabilities are attractive to industry partners while growing health technology research activities within Ireland”.
Click here to read the full article on the TRIL website
About the TRIL Centre
The TRIL Centre looks at the physical, social and cognitive consequences of ageing and develops technologies to address them…’making longer lives better’.
TRIL is an active collaboration between researchers in academic, clinical and industry settings. Operating as a virtual centre with researchers based in UCD, TCD, NUIG and Intel, it tackles the problems associated with demographic ageing. The centre harnesses multidisciplinary ageing research, clinical expertise and enabling technology development and evaluation to support independent living. For more visit www.trilcentre.org.
Intel is a world leader in computing innovation. The company designs and builds the essential technologies that serve as the foundation for the world’s computing devices.
Additional information about Intel is available at: